Despite this limitation, there is significant consumer demand for these drugs beyond their approved uses
Losing 5 to 10% of body weight in addition to improved blood pressure or cholesterol is considered clinically significant
The following results were seen after 12 weeks of treatment as compared with before treatment: people who took Vyvanse had, on average, 3.87 to 3.92 fewer binge days* per week people who took a placebo had, on average, 2.26 to 2.51 fewer binge days per week In another clinical trial, adults took Vyvanse for 12 weeks
The main concern is that persistent nausea, vomiting, or diarrhea may cause dehydration and reduced kidney perfusion
The thing is, the company had already submitted its application for approval before these results were released, and that application is based on earlier studies showing strong weight loss and blood sugar improvements on their own